Pfizer India (PFIZER) Q2 24/25 earnings summary

Executive summary

• Unaudited financial results for the quarter and half year ended September 30, 2024, were approved by the Board on October 28, 2024.

• Financials prepared in accordance with Ind AS and reviewed by statutory auditors with no modifications.

Financial highlights

• Revenue from operations for Q2 FY25 was ₹588.59 crore, up from ₹575.21 crore in Q2 FY24.

• Net profit for Q2 FY25 stood at ₹158.35 crore, compared to ₹148.96 crore in Q2 FY24.

• EPS for Q2 FY25 was ₹34.61, up from ₹32.56 in Q2 FY24.

• Total income for H1 FY25 was ₹1,236.36 crore, up from ₹1,176.10 crore in H1 FY24.

• Net profit for H1 FY25 was ₹309.06 crore, compared to ₹242.49 crore in H1 FY24.

Outlook and guidance

• No forward-looking guidance or outlook was provided.